NEVVI Medicare utilization intelligence
or

← back

Provider profile

ZOLOTAREVSKAYA, IRINA M.D.

Pulmonary Disease · NPI 1730127622 · REGO PARK, NY

1
Groups
22
Codes · 2024
8,087
Disclosed services

ZOLOTAREVSKAYA, IRINA is a Pulmonary Disease in REGO PARK, NY, a member of 1 medical group, who billed 22 distinct codes to Medicare Part B in 2024.

Groups: NEW YORK UNIVERSITY (NEW YORK, NY)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

8,087
disclosed services
22
codes billed to Medicare Part B
Prior year · CY2023 7,991 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0517 Injection, benralizumab, 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
94060 Test to measure expiratory airflow and volume changes before and after medication administration
94729 Test to examine how well the lungs exchange gases
94726 Test to determine lung volumes using sensors
95012 Test to measure the level of nitric oxide gas
94664 Evaluation of use of breathing device
94618 Test for exercise-induced lung stress
36415 Insertion of needle into vein for collection of blood sample
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96372 Injection of drug or substance under skin or into muscle
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99406 Smoking and tobacco use intensive counseling, 4-10 minutes
94010 Test to measure expiratory airflow and volume
G0008 Administration of influenza virus vaccine
95810 Sleep study in sleep lab (6 years or older)
90662 Influenza vaccine split virus, preservative free
95811 Sleep study in sleep lab with continuous airway pressure (6 years or older)
G0009 Administration of pneumococcal vaccine
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99442 Telephone medical discussion with physician, 11-20 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.